rfhg_201586.1

Basic information about the TSS

---

TSS ID: rfhg_201586.1 Species: human Chr: chr18		Start: 12658699 End: 12658699 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2983735,EH38E1901307)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000589405.5:39 ENST00000585331.6:39 GeneID: 56984 HGNC/MGI_ID: HGNC:24929 UniProt_ID: Q969U7 Nearer transcript ids and distances: AF161378:40 AF068295:40 ENST00000400512.1:-453 view more...

Gene_name: proteasome assembly chaperone 2 Gene_symbol: PSMG2 Gene_synonyms: CLAST3 HCCA3 HsT1707 MDS003 MGC15092 PAC2 Gene_source: HGNC:24929

TATA-Box annotation

---

Distance to TSS:	-40
Nearest PromoterID:	NM_147163
Entrez ID:	56984
Nearest Unigene:	Hs.464652
Nearest Refseq:	NM_020232
Nearest Ensembl:	ENSG00000128789
Gene Name:	proteasome assembly chaperone 2
Gene Alias:	CLAST3|HCCA3|HsT1707|MDS003|PAC2|TNFSF5IP1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PSMG2 p2@PSMG2 p3@PSMG2 p4@PSMG2 p5@PSMG2 p6@PSMG2
Sample		p1@PSMG2	p2@PSMG2	p3@PSMG2	p4@PSMG2	p5@PSMG2	p6@PSMG2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	53.57	5.84	4.29	0.00	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	56.04	7.28	3.44	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	57.49	4.44	4.82	0.19	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	46.57	4.99	4.57	0.83	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.69	5.85	6.52	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	50.58	5.04	6.98	0.39	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	76.69	9.80	10.89	0.65	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	62.01	5.57	8.24	0.00	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	60.48	4.49	5.13	0.64	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	50.43	6.38	8.11	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	51.34	5.26	9.70	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	51.63	3.25	8.13	0.81	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	66.09	1.61	0.97	4.19	1.93	3.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	61.34	2.26	1.20	3.16	1.95	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	48.52	2.42	1.10	2.63	1.54	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	55.58	3.02	2.01	2.51	1.26	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	57.88	1.75	1.75	3.49	1.53	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	63.69	2.11	2.11	2.95	0.42	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	60.25	2.67	2.67	2.13	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	65.89	3.01	0.90	3.01	2.56	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	64.82	2.94	1.20	2.67	2.00	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	66.29	2.93	1.38	3.45	1.55	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	66.31	2.84	1.55	2.84	1.16	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	64.06	3.88	0.49	3.64	1.94	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	60.11	3.35	2.06	2.06	0.77	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	59.50	1.90	2.22	3.48	0.95	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	74.73	1.65	1.10	1.10	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	62.24	3.06	3.06	3.54	3.06	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	58.47	1.94	1.94	1.29	0.97	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	64.79	2.53	1.99	2.71	0.72	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	61.76	2.72	2.09	2.09	0.42	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	67.02	1.37	1.37	1.95	1.17	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	64.15	1.90	3.17	2.32	1.27	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	94.02	2.64	4.12	1.98	0.49	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	59.09	3.37	2.06	2.06	0.56	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	54.80	3.07	3.26	2.49	1.72	4.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	52.93	2.45	1.84	2.25	2.04	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	64.27	3.83	2.42	2.22	0.60	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	59.15	1.62	2.97	1.35	0.81	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	58.58	2.88	2.40	1.92	2.16	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	58.81	4.71	3.29	1.41	0.24	3.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	68.07	3.95	3.95	2.34	0.73	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	52.30	2.53	2.95	2.74	2.32	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	58.74	3.32	2.97	0.52	0.70	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	50.80	2.41	1.81	2.21	1.41	2.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	55.60	3.02	0.70	3.26	0.70	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	49.18	2.64	2.40	0.72	1.68	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	44.41	4.17	3.58	1.19	1.19	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	51.94	3.35	2.87	0.96	0.24	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	52.37	3.24	1.62	2.43	0.61	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	55.95	4.71	3.07	1.02	0.61	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	58.48	2.67	3.11	2.45	0.67	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	13.99	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	56.78	7.81	1.06	1.77	0.71	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	51.36	3.98	2.65	1.33	1.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	129.20	10.07	10.91	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	68.43	4.13	5.05	0.92	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	55.75	4.21	1.62	0.65	0.65	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	54.28	4.18	3.21	1.28	0.64	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	76.07	3.77	4.40	3.46	1.57	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	52.88	4.94	1.41	0.00	0.71	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	38.69	2.80	0.56	0.56	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	79.61	5.57	7.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	56.74	2.38	6.80	1.70	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	40.94	3.57	1.30	0.32	0.97	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	50.05	2.48	1.77	1.06	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.98	2.44	1.46	0.49	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	42.64	3.97	2.48	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	37.06	4.22	0.94	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	49.35	4.97	3.64	0.66	0.33	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	44.24	5.88	0.31	1.24	0.93	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	47.70	2.75	1.83	0.00	0.92	0.61
Adipocyte - breast, donor1	11376-118A8	61.29	4.91	3.64	0.32	0.32	0.63
Adipocyte - breast, donor2	11327-117E4	42.03	4.17	1.76	0.32	0.96	1.93
Adipocyte - omental, donor1	11473-119C6	59.03	5.22	3.94	0.00	0.13	0.89
Adipocyte - omental, donor2	11474-119C7	50.08	0.75	2.24	1.49	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	50.91	2.01	3.35	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	60.61	1.28	1.28	0.00	0.00	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	30.79	3.30	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	45.16	2.71	0.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	73.85	3.48	0.70	0.00	0.70	1.39
Adipocyte differentiation, day04, donor1	13019-139D4	41.85	3.72	2.35	0.98	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	36.81	2.32	2.06	0.51	0.26	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	36.24	2.23	1.39	1.12	1.12	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	41.73	1.76	1.76	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	40.06	5.39	1.53	0.72	0.48	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	41.64	2.26	0.97	0.00	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	31.99	3.20	2.13	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	35.06	1.67	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	45.33	2.91	0.00	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	38.43	3.01	2.51	0.50	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	32.07	2.62	0.98	0.65	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	19.18	3.96	0.61	0.00	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	37.57	6.41	1.99	0.00	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	19.36	0.72	0.00	1.08	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	1.20	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	48.93	2.70	0.18	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	0.00	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	32.87	4.93	0.62	0.21	0.62	0.62
Anulus Pulposus Cell, donor1	11248-116E6	104.24	3.66	2.86	0.69	0.69	0.69
Anulus Pulposus Cell, donor2	11463-119B5	77.64	0.49	1.22	0.49	0.73	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.49	1.35	1.80	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	47.32	2.17	0.43	0.87	0.87	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	2.14	2.14	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	45.74	1.20	2.39	0.60	0.30	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	53.12	3.79	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	44.88	5.28	1.32	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.16	1.95	2.60	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.50	3.40	1.46	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	35.04	5.94	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	38.42	1.88	1.13	0.75	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	35.56	0.73	2.18	0.73	0.00	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	1.25	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	47.28	3.62	2.47	0.82	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	5.46	2.73	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	51.27	2.87	1.36	0.45	0.75	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	36.43	2.14	2.68	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	40.24	3.02	1.32	0.38	0.38	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	38.49	2.94	0.53	0.80	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	39.02	0.98	1.95	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	45.11	2.49	2.49	0.50	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	36.02	2.40	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	44.94	2.57	1.54	0.51	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	43.20	3.40	2.43	1.94	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	55.40	4.17	2.28	0.00	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	41.04	1.71	1.71	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	46.82	2.35	1.28	0.21	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.36	2.06	0.77	0.26	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	43.17	4.22	2.82	2.82	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	42.77	4.82	1.61	1.61	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	34.96	2.14	0.00	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	36.27	0.58	2.34	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	45.16	1.51	0.30	0.90	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	46.33	4.75	2.38	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	38.65	2.03	0.00	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	39.73	2.80	2.29	0.51	0.76	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	35.58	2.54	0.64	1.27	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.45	3.45	0.86	0.43	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	43.18	1.91	1.48	0.42	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	46.11	1.74	0.87	0.58	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	37.79	1.89	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	37.63	3.39	0.85	0.34	0.00	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	8.45	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	43.10	1.93	2.14	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	42.72	2.41	4.21	0.60	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	31.35	2.19	2.92	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	48.05	1.84	1.84	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	47.54	3.05	2.54	0.76	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	48.93	3.30	2.89	0.41	0.00	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	41.31	1.53	1.84	0.92	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	31.55	2.87	0.48	0.48	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	44.35	2.22	0.89	0.22	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	0.00	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	49.30	2.77	0.55	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	47.13	2.65	1.85	0.53	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	45.07	2.18	1.82	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	68.41	3.68	2.21	0.98	0.86	1.23
Astrocyte - cerebellum, donor2	11580-120F5	41.59	2.57	2.05	0.51	0.68	1.54
Astrocyte - cerebellum, donor3	11661-122F5	24.33	3.15	0.00	0.21	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	62.40	5.93	3.14	4.18	1.74	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	47.08	6.47	1.78	2.26	1.46	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	56.23	6.56	1.04	1.49	1.34	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	100.35	5.16	1.49	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	98.47	5.64	1.63	0.13	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	86.83	4.67	1.82	0.00	0.00	0.00
Basophils, donor1	12241-129G9	74.01	3.40	2.35	0.00	0.00	0.00
Basophils, donor2	12242-129H1	107.16	7.58	8.30	0.00	0.00	0.00
Basophils, donor3	12243-129H2	72.91	3.09	2.94	0.15	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	30.40	3.02	0.00	0.43	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	11.43	0.46	0.00	0.00	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	30.13	0.00	0.63	2.51	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	22.04	1.66	0.21	0.21	0.42	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	40.07	3.45	0.46	0.92	1.15	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	32.93	2.70	0.18	0.36	0.36	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	127.79	3.50	3.40	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	172.35	6.06	1.86	0.47	2.33	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	138.46	3.84	5.12	0.64	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	196.50	0.00	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	63.12	2.25	1.69	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	50.48	1.67	1.11	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	44.13	3.95	2.41	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	98.78	2.83	2.55	1.13	4.25	2.55
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	77.33	3.41	0.76	1.90	1.52	3.79
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	87.77	2.63	1.64	1.31	1.31	6.90
CD14+ monocytes - mock treated, donor1	11863-125A9	46.54	1.30	3.32	1.01	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	35.30	0.60	1.81	1.51	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	44.30	2.61	2.13	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	29.29	0.84	3.01	0.50	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.18	1.10	2.76	1.10	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	35.45	1.74	2.23	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	28.78	2.15	2.74	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	26.00	1.07	2.85	0.71	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	55.06	4.35	4.57	0.44	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	29.73	1.87	1.64	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	41.71	2.11	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	41.05	3.33	3.33	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	43.58	1.04	3.12	0.45	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.92	1.20	2.39	1.80	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	53.51	2.08	4.16	0.83	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.74	0.69	1.14	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.13	0.68	2.26	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.31	1.31	0.00	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	40.62	2.96	3.50	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	55.83	2.27	3.49	0.35	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	60.18	2.10	3.37	0.42	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.82	0.37	0.92	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.57	1.76	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.11	0.00	0.88	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.12	1.74	2.27	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	35.68	1.86	2.60	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	67.25	1.94	3.66	0.65	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.47	0.00	1.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.53	0.93	1.62	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	28.07	0.70	2.09	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	105.28	3.71	2.62	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	126.58	2.54	3.93	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	131.49	5.85	4.33	0.22	0.22	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	131.90	6.85	3.27	0.31	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	117.71	3.14	3.49	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	82.05	4.68	2.45	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	120.95	5.61	3.32	0.00	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	113.95	6.15	2.20	0.00	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	117.27	6.32	5.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	154.46	8.13	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	142.38	4.75	4.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	155.34	7.25	3.11	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	139.66	7.46	4.26	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	146.88	9.11	5.90	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	159.34	5.62	3.51	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	147.46	6.27	3.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	174.01	5.27	7.91	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	87.94	4.11	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	98.66	1.45	2.18	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	57.55	5.05	5.55	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	181.42	43.23	1.62	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	156.60	31.56	3.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	91.37	5.02	9.04	3.01	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	142.70	2.81	10.11	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	131.14	6.76	2.63	0.00	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	161.45	8.34	5.64	0.23	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	67.13	12.85	4.64	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	87.57	14.70	1.84	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	78.69	9.76	3.96	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	100.31	8.17	2.30	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	101.97	9.66	2.02	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	111.53	11.79	1.72	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	127.53	11.85	2.84	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	164.34	14.05	1.40	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	89.00	9.89	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	96.10	10.98	2.60	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	88.63	10.85	2.20	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	83.99	9.99	1.29	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	125.97	11.21	3.14	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	147.09	16.07	3.84	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	109.12	5.28	2.20	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	99.09	6.75	3.79	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	96.20	9.97	2.49	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	87.54	8.02	1.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	89.19	13.60	0.54	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	113.09	13.40	1.07	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	89.66	12.55	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	119.79	12.42	2.78	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	95.31	11.91	3.25	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	95.62	10.72	3.15	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	124.38	11.63	3.03	0.00	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	121.31	12.13	4.33	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	102.42	11.77	3.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	167.76	15.34	3.46	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	158.79	9.23	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	154.94	20.94	4.19	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	165.33	7.75	2.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	161.47	7.36	3.19	0.25	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	170.94	10.78	4.62	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	160.08	13.25	3.58	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	153.73	18.00	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	80.87	8.18	5.89	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	72.46	7.51	1.13	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	71.96	9.09	7.83	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	60.79	3.44	0.92	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	54.40	2.64	2.16	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	56.36	3.56	1.92	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	78.36	6.60	1.50	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	49.44	4.56	1.92	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	56.16	2.96	2.27	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	71.27	6.08	1.30	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	73.70	4.74	1.32	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	79.97	4.92	1.64	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	84.83	4.23	2.11	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	76.40	4.36	1.45	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	75.13	4.80	2.93	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	43.78	3.06	1.31	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	41.44	1.82	1.37	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	34.31	1.49	3.73	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	64.47	5.04	2.52	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	50.35	3.74	0.86	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	52.09	4.71	0.94	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	82.08	7.29	3.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	75.66	5.84	1.85	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	65.40	6.09	2.24	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	74.20	2.68	3.06	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	62.66	3.94	1.97	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	60.51	3.03	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	77.08	5.62	3.21	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	74.84	4.90	4.20	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	84.15	5.01	4.01	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	23.76	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	59.78	2.96	2.47	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	53.46	2.95	1.79	0.95	0.32	0.53
Chondrocyte - de diff, donor1	11261-116G1	72.80	4.16	2.43	1.39	1.04	2.08
Chondrocyte - de diff, donor2	11338-117F6	61.12	3.55	1.42	0.36	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	60.30	4.66	1.71	1.82	1.14	0.68
Chondrocyte - re diff, donor2	11339-117F7	60.88	2.69	3.58	1.79	0.90	3.58
Chondrocyte - re diff, donor3	11411-118E7	33.57	2.83	1.21	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	79.30	5.39	1.03	0.92	1.38	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	36.55	2.57	1.92	0.43	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	51.68	4.07	1.42	0.97	1.06	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	72.90	7.15	6.14	1.65	1.01	1.28
Corneal Epithelial Cells, donor1	11526-119I5	29.64	2.63	0.88	0.88	0.22	1.10
Corneal Epithelial Cells, donor2	11606-120I4	30.72	3.41	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	31.19	4.86	1.02	0.00	0.77	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.13	3.14	1.82	0.66	0.33	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	49.83	2.52	1.26	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	96.62	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	43.63	2.27	0.22	0.11	0.22	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	113.42	8.54	2.39	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	124.05	11.75	6.53	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	142.76	6.29	3.39	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	36.02	4.34	0.67	1.17	0.83	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	4.11	1.17	0.59	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	33.94	1.41	0.00	0.85	0.57	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	29.10	1.97	0.00	0.79	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	44.79	3.20	0.87	0.29	0.58	2.04
Endothelial Cells - Artery, donor2	11341-117F9	42.82	5.65	1.41	0.94	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	33.13	3.51	1.23	1.05	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	46.99	3.77	0.66	4.43	1.11	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	44.42	3.96	1.22	5.48	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	39.75	3.38	0.56	1.13	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	60.32	1.19	1.49	0.00	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	35.41	3.64	1.56	1.04	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	36.72	1.84	0.85	0.28	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	83.22	4.00	2.80	0.00	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	2.62	1.05	0.52	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	85.11	5.96	1.37	2.36	1.37	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	28.68	1.96	0.43	3.26	0.87	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	32.85	3.54	0.49	4.40	2.44	0.98
Endothelial Cells - Vein, donor1	11267-116G7	17.06	2.28	1.14	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	25.84	2.10	0.70	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	43.18	4.08	0.94	1.10	0.94	1.57
Eosinophils, donor1	12244-129H3	76.23	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	21.45	3.30	4.95	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	7.13	10.70	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.12	2.69	0.24	0.24	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	28.33	2.87	1.64	1.23	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	30.11	2.85	1.20	0.55	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.78	4.77	2.06	0.87	0.76	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	68.89	5.46	1.70	0.36	0.36	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.03	3.00	1.50	0.41	0.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	35.23	3.16	1.05	0.11	0.21	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.25	1.84	1.84	1.05	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.15	4.65	0.66	0.66	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	43.55	1.81	0.91	1.36	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	25.01	1.52	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	22.87	2.84	1.26	1.42	0.63	0.95
Fibroblast - Cardiac, donor4	11452-119A3	56.38	3.33	1.52	0.30	1.52	1.21
Fibroblast - Cardiac, donor5	11456-119A7	69.92	3.68	0.51	0.51	0.89	1.40
Fibroblast - Cardiac, donor6	11460-119B2	60.94	4.85	1.21	0.91	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	57.35	1.34	0.94	0.67	0.40	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	46.59	1.29	0.86	0.00	0.86	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	1.46	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	62.27	5.54	0.69	0.23	1.15	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	116.18	4.92	2.04	0.51	0.34	1.53
Fibroblast - Dermal, donor1	11269-116G9	56.82	3.76	2.11	0.00	0.70	1.17
Fibroblast - Dermal, donor2	11346-117G5	33.02	2.83	0.94	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	66.85	6.65	1.21	0.48	0.12	0.36
Fibroblast - Dermal, donor4	11450-119A1	51.89	6.90	1.24	1.02	0.68	1.13
Fibroblast - Dermal, donor5	11454-119A5	70.48	5.58	1.57	0.70	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	69.84	5.68	1.95	0.49	0.97	0.65
Fibroblast - Gingival, donor1	11237-116D4	67.67	6.25	1.25	1.46	1.04	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	50.57	3.14	2.36	1.57	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	72.22	8.30	0.13	0.13	0.40	0.53
Fibroblast - Gingival, donor3	11394-118C8	60.62	4.06	0.58	0.39	0.87	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	66.49	4.16	2.08	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.06	3.88	1.06	0.70	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.84	5.77	2.49	0.47	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	52.06	7.84	1.89	0.95	1.49	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.94	0.35	0.35	1.06	0.35	2.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	57.62	4.97	1.75	0.88	0.44	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	66.54	5.45	1.64	0.14	0.14	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	59.01	7.24	1.65	0.33	0.22	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	57.23	4.11	1.61	2.05	2.49	3.52
Fibroblast - Lung, donor1	11270-116H1	46.22	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	5.97	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	65.84	6.12	0.84	0.42	0.84	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	51.65	1.67	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	1.40	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	12.59	1.96	0.84	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	61.71	6.50	2.84	0.00	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	75.07	5.63	1.36	0.19	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	58.09	9.25	0.91	0.76	1.06	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	42.23	4.28	1.84	1.22	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.35	3.82	1.14	0.38	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	52.11	4.05	1.35	0.54	0.54	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	37.00	2.67	0.81	0.58	0.81	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	58.03	7.41	2.32	1.55	0.44	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.63	5.89	1.63	0.41	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	25.39	4.01	0.00	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	56.93	1.98	0.79	1.19	1.98	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	46.64	2.78	1.79	0.00	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	61.46	3.20	1.95	0.00	0.89	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	65.04	3.55	0.99	0.39	0.39	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.99	3.61	0.60	0.60	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	65.63	3.13	1.94	1.30	0.43	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.46	1.52	1.52	1.27	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	51.68	2.63	2.13	0.82	1.31	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	43.71	3.61	2.61	0.20	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	72.13	3.52	2.21	0.30	0.80	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.66	3.32	1.81	0.91	1.21	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	62.71	3.31	1.49	0.58	0.25	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	111.80	3.08	3.08	1.03	0.85	2.91
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.32	1.31	1.97	0.66	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	55.50	3.83	2.56	0.43	0.43	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	52.29	5.90	1.69	0.34	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	69.63	6.90	2.82	0.47	0.16	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	310.24	0.00	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	4.36	3.49	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.51	6.07	1.56	0.87	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	45.54	4.16	2.60	0.78	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	36.03	4.34	1.02	1.28	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	87.27	1.53	1.53	3.06	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	98.90	7.02	8.29	1.91	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	120.10	8.27	3.71	2.00	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	73.90	5.24	0.83	2.76	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.92	7.08	2.05	1.83	2.97	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	93.72	4.56	3.76	2.18	1.19	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	71.11	5.02	2.64	2.38	0.53	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	49.25	3.91	2.28	6.52	3.59	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	118.07	6.63	5.75	1.77	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	61.76	5.94	2.83	1.41	0.71	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	54.68	4.19	1.97	2.09	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	60.44	5.91	3.76	1.34	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.79	3.22	0.62	1.12	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	55.23	6.09	1.66	1.11	0.69	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	50.83	3.66	2.64	1.02	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	56.36	3.65	1.37	1.83	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	48.71	3.49	1.25	1.87	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	46.34	3.72	0.44	2.40	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	67.37	2.66	1.18	1.48	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.46	4.13	0.79	1.11	0.79	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	50.27	4.24	0.67	1.34	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	51.01	2.82	1.01	0.60	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	48.18	4.92	0.51	1.19	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.10	6.03	2.31	1.77	0.62	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.38	4.58	1.46	1.25	0.52	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	54.14	3.07	0.85	1.37	0.85	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.70	4.87	0.11	0.77	0.44	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.32	3.33	1.83	1.75	0.42	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.76	3.06	1.84	1.02	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	56.32	3.92	0.83	2.06	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	47.62	3.11	0.69	1.15	0.46	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.69	4.84	0.83	1.00	0.83	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	50.04	2.42	0.66	0.66	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	53.01	4.30	0.74	1.72	0.74	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	45.22	2.43	2.11	1.13	1.13	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	64.14	4.81	0.32	0.96	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.92	2.75	0.76	0.47	0.66	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.03	3.32	0.95	0.32	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.44	3.04	0.61	0.61	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.82	4.29	0.94	0.84	1.05	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.98	3.07	0.66	0.88	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	49.38	4.21	1.12	0.56	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	33.24	2.31	0.74	0.56	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	41.71	3.21	2.14	0.27	1.34	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	40.09	2.75	2.30	0.31	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	40.03	2.72	0.65	0.78	0.39	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	50.96	1.36	0.27	1.36	1.08	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.99	2.58	2.21	0.55	1.47	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	47.15	3.29	0.66	0.22	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	1.98	0.00	4.96	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.07	4.09	0.92	0.53	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.69	3.43	0.81	1.21	0.40	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	40.16	2.29	0.76	1.52	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	97.54	4.98	5.57	2.39	1.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	58.70	3.85	2.31	1.54	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	69.15	4.71	2.86	1.02	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	80.42	7.51	6.88	1.88	0.00	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	74.31	6.78	5.09	2.26	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	80.71	2.31	3.23	2.77	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	79.19	0.00	4.95	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	68.47	4.64	3.87	0.77	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	59.37	8.02	4.81	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	59.12	3.48	3.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	73.23	5.21	2.28	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	69.59	6.18	4.53	0.41	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	10.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	66.56	3.36	3.08	0.84	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	74.52	3.27	3.92	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.01	2.52	2.52	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	65.84	3.82	1.27	1.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	63.86	3.40	2.38	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	114.85	12.53	6.26	8.35	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.61	1.15	1.15	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	60.38	4.14	0.89	0.89	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	54.21	10.16	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	67.93	4.97	7.04	0.83	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	59.83	5.29	4.37	0.23	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.12	5.38	2.69	0.38	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	65.85	3.26	2.61	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	78.92	3.34	3.34	0.00	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	74.36	5.78	3.08	1.54	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.33	2.40	10.61	2.05	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	2.48	2.48	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	68.89	2.83	0.47	2.36	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	72.42	5.43	0.00	3.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	71.21	5.60	4.07	2.54	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.99	2.39	1.99	1.60	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	84.86	3.45	1.48	2.47	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	69.65	1.18	3.54	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	78.77	4.67	1.75	2.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	70.22	3.95	1.76	3.07	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	56.80	1.70	3.39	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	46.56	3.58	6.57	2.98	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.60	4.37	2.43	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	37.66	2.28	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.50	2.91	1.66	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	46.10	1.12	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	68.51	0.63	1.27	0.32	0.95	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	73.10	1.25	1.25	0.42	0.00	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	52.10	7.31	3.37	0.23	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	53.68	6.58	2.87	0.00	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	55.06	5.46	3.19	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	52.36	8.42	3.61	0.22	0.44	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	53.08	5.37	2.58	0.00	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	44.78	6.24	2.15	0.43	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	56.29	8.09	2.49	0.12	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	50.09	6.00	2.06	0.00	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	44.21	7.37	4.16	0.32	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	57.08	0.56	0.56	0.56	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	29.00	3.03	0.87	0.87	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	2.64	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	64.20	3.53	0.71	0.71	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	32.69	1.45	0.00	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	61.54	4.37	2.27	0.17	0.00	0.52
Hepatocyte, donor1	11523-119I2	26.63	1.21	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	34.47	3.23	3.23	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	28.84	2.45	0.00	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	132.50	8.48	3.92	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	138.78	9.26	4.54	0.70	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	50.49	3.16	0.55	0.41	0.14	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	48.45	8.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	10.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	48.73	6.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	55.02	3.33	5.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	47.64	14.56	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	6.65	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	43.46	10.71	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	23.20	4.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	47.16	4.52	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	8.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.08	8.96	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	33.58	7.98	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	46.61	4.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	35.08	7.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.04	7.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.02	4.53	1.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	32.28	5.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	44.00	3.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	5.47	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	48.56	10.00	1.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	9.95	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	30.87	4.94	1.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	9.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.99	4.87	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	4.43	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	40.98	6.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	11.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	33.07	10.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	17.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	5.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	21.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	4.23	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	23.17	2.53	1.47	0.08	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	24.60	1.17	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	59.16	6.91	0.95	0.09	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	76.96	4.09	0.68	0.34	0.11	0.45
Keratocytes, donor1	11527-119I6	80.46	14.78	0.69	2.06	1.38	1.03
Keratocytes, donor2	11607-120I5	25.78	3.52	0.00	1.17	1.17	1.17
Keratocytes, donor3	11688-122I5	64.61	4.74	0.20	0.59	0.40	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	43.15	2.16	1.08	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	61.01	3.81	0.58	1.38	0.92	1.50
Lens Epithelial Cells, donor3	11690-122I7	28.36	1.31	1.61	0.10	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	59.29	3.68	1.90	0.83	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	48.56	3.35	1.12	0.28	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	58.56	5.35	1.57	0.16	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	48.93	4.30	1.61	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	39.71	3.47	1.58	0.32	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	48.52	3.23	1.19	0.22	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	48.43	0.41	1.23	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	39.44	2.28	2.28	0.76	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	48.28	1.97	0.42	0.00	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.14	3.16	0.40	0.40	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.57	2.91	2.13	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	40.73	3.15	0.56	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	54.01	2.79	2.44	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.80	3.10	1.43	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	51.23	3.16	1.24	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	48.35	3.70	2.46	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	37.10	2.49	1.25	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.14	3.11	0.91	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	49.04	3.62	1.97	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	38.37	1.46	1.17	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	36.09	2.74	0.25	0.50	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.38	2.91	2.42	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.36	4.04	1.35	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	48.90	3.48	1.51	0.15	0.45	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	44.07	4.67	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	44.60	3.56	1.26	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	49.92	2.56	1.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	60.53	2.75	0.69	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	43.84	4.52	1.69	0.38	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	39.23	2.97	0.95	0.11	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	37.31	1.45	1.94	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	45.65	1.65	0.66	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	43.61	3.35	0.99	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	50.72	2.96	1.48	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	44.47	4.20	2.72	0.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	41.39	3.30	1.24	0.14	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	54.04	5.15	1.93	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.00	2.13	2.74	0.00	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	52.49	3.64	0.84	0.14	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	51.20	5.69	1.42	0.36	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	37.81	0.97	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	38.90	2.02	0.16	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	48.70	3.94	2.15	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	34.63	1.63	0.33	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	28.96	1.41	0.24	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	52.84	3.59	1.98	0.50	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	33.81	1.28	2.05	1.02	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	46.25	2.69	1.19	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	4.53	4.53	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	52.93	3.84	0.77	0.77	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	48.24	0.74	1.48	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	39.77	3.39	4.23	1.69	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	45.01	2.81	2.81	2.11	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	43.90	2.80	3.74	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	42.77	0.52	0.00	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	46.39	2.38	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	49.76	4.30	4.07	0.90	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	46.53	3.20	2.91	2.33	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.27	2.25	1.35	2.25	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	56.63	4.34	4.20	2.03	0.81	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	41.08	1.54	2.57	1.03	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.93	0.71	2.47	2.12	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	41.98	2.67	2.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	41.77	0.51	3.57	1.53	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	47.49	3.20	4.00	1.33	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	50.07	4.35	3.59	1.89	1.32	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.79	3.68	1.84	0.61	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	1.63	3.26	0.82	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.07	2.92	1.04	1.25	0.00	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	47.08	3.64	3.08	2.52	0.84	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	47.40	5.15	2.06	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	44.42	5.23	2.61	1.45	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	42.15	3.89	2.09	1.79	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	54.77	1.66	1.11	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.71	4.60	2.47	1.06	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.73	4.43	3.69	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	3.45	2.30	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	46.43	1.92	4.61	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	37.93	1.70	2.26	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	46.77	2.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.03	2.71	2.26	1.36	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	34.47	0.72	2.15	1.44	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	43.32	4.48	2.24	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	47.94	4.46	2.60	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	34.03	3.45	3.02	2.15	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	33.40	1.71	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	37.32	4.00	1.33	1.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	40.42	0.00	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.26	2.84	2.13	2.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	42.62	1.72	2.41	1.37	1.37	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	33.28	2.15	2.68	1.07	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	37.03	2.02	0.67	1.35	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	37.41	4.07	1.48	2.96	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	2.33	4.65	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	1.06	2.12	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	33.21	4.40	1.60	1.20	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	42.89	4.36	2.91	2.18	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	55.96	6.13	2.30	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	55.25	2.47	1.97	0.00	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	35.76	0.94	4.70	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	63.36	5.53	2.01	1.51	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	47.32	5.41	0.90	1.80	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	53.35	5.16	3.44	1.72	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	48.10	5.34	2.67	2.23	1.78	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	47.71	2.74	3.13	1.56	1.17	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	51.46	1.32	2.64	0.66	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	68.50	4.15	1.04	1.56	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	69.14	7.44	1.75	2.63	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	44.73	2.80	1.12	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	53.88	3.09	3.09	0.88	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.60	2.70	2.70	1.54	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	56.21	2.53	3.54	1.52	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	49.50	5.77	1.92	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	47.71	5.57	2.39	1.59	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.28	1.82	4.25	2.43	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	45.65	2.77	2.08	0.69	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.16	3.42	2.66	3.42	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.03	4.65	4.65	2.58	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.19	0.60	3.02	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.27	3.17	4.44	1.58	1.58	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	42.65	3.20	2.13	2.13	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	49.42	4.60	4.60	1.15	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.97	2.06	3.09	1.54	2.06	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	34.66	1.41	3.54	1.41	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	51.64	2.27	3.40	1.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.85	2.08	1.66	2.50	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	25.06	2.35	3.13	2.35	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	44.68	1.25	2.51	1.67	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	42.75	5.11	3.72	0.93	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	1.34	2.01	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	45.98	1.07	3.21	1.60	2.14	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	33.54	2.83	3.23	1.62	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	36.71	1.84	2.75	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	34.68	0.89	0.89	0.00	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	0.57	1.71	2.28	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	31.44	3.07	2.30	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.83	1.64	1.09	1.64	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.84	2.67	1.78	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.83	3.38	1.82	1.30	1.30	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	37.80	1.33	2.65	1.33	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	4.16	2.08	4.16	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	63.36	3.65	1.14	1.60	2.05	2.73
Macrophage - monocyte derived, donor2	11313-117C8	49.91	3.67	1.84	0.92	1.10	1.28
Macrophage - monocyte derived, donor3	11389-118C3	52.83	4.59	1.57	0.00	0.92	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	66.91	5.31	3.72	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	51.02	2.54	1.74	0.00	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	62.27	4.73	4.45	0.42	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	85.10	9.17	2.79	0.70	0.30	0.40
Mammary Epithelial Cell, donor2	11350-117G9	70.94	6.08	2.61	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	42.15	4.24	0.50	0.00	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	70.51	0.68	4.07	0.00	2.71	0.68
Mast cell, donor1	11563-120D6	74.83	2.27	2.92	0.43	0.97	2.38
Mast cell, donor2	11565-120D8	32.39	2.08	2.67	1.49	0.59	0.59
Mast cell, donor3	11566-120D9	62.81	2.48	1.13	2.70	2.25	2.03
Mast cell, donor4	11567-120E1	34.22	4.08	2.30	3.90	1.42	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	75.19	5.43	0.22	0.33	1.00	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	83.47	1.75	2.33	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	97.05	6.88	0.46	0.23	1.15	0.69
Mast cell, expanded, donor8	11941-126A6	75.98	3.85	2.51	0.33	1.34	0.67
Melanocyte - dark, donor1	11502-119F8	68.06	4.68	3.68	0.50	0.10	0.20
Melanocyte - dark, donor2	11582-120F7	61.60	3.11	1.73	1.38	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	74.76	4.78	1.52	0.51	1.09	2.32
Melanocyte - light, donor1	11274-116H5	25.39	1.65	0.24	0.47	1.65	1.18
Melanocyte - light, donor2	11351-117H1	30.03	0.68	0.68	1.36	1.36	0.00
Melanocyte - light, donor3	11423-118G1	25.15	3.47	0.00	0.87	0.00	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	53.83	6.14	0.42	0.52	1.67	1.35
Melanocyte, donor2 (MC+2)	12739-135I3	65.62	2.42	1.61	1.08	0.81	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	42.32	2.68	1.07	1.07	1.34	0.54
Meningeal Cells, donor1	11493-119E8	61.91	2.73	3.23	1.12	0.87	1.36
Meningeal Cells, donor2	11573-120E7	57.66	2.64	0.88	0.44	1.76	1.32
Meningeal Cells, donor3	11654-122E7	57.87	6.11	2.20	0.73	0.41	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	76.99	7.41	1.14	0.00	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	42.16	2.21	1.81	0.50	0.20	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	19.71	1.31	1.31	0.00	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	1.31	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	46.64	12.92	1.44	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	57.81	2.33	1.48	0.64	0.21	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	45.24	4.52	2.51	0.50	1.01	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	44.61	3.08	3.08	1.76	0.22	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	43.10	8.04	0.00	1.46	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.96	4.09	1.23	0.20	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	72.58	2.63	1.66	0.83	0.42	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	16.73	1.12	1.12	0.37	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.97	3.42	1.45	1.05	0.39	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.74	0.59	0.00	0.00	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.22	1.28	1.28	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	86.13	9.92	4.96	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	52.54	2.81	0.94	0.31	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	52.25	5.81	2.18	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	42.16	6.10	1.86	0.27	0.00	0.80
Mesothelial Cells, donor2	12156-128G5	38.04	3.00	2.50	0.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	29.99	3.25	1.73	0.14	0.22	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	0.00	0.00	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	43.10	1.97	1.48	2.71	0.25	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.45	3.24	0.88	1.47	0.59	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.43	3.10	0.62	1.55	0.31	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.66	2.49	0.83	0.21	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	43.30	1.25	2.00	1.00	0.25	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.74	1.40	0.93	0.93	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	41.46	1.42	0.20	0.61	0.61	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.13	0.40	2.38	0.40	1.98	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	41.59	2.65	3.54	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.21	1.90	3.04	0.76	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	0.00	0.00	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.17	1.49	0.85	1.06	0.21	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	0.00	0.00	0.00	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	26.23	0.89	0.30	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	39.39	2.76	1.25	1.25	0.25	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.23	2.14	1.66	0.48	0.24	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	0.00	0.00	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.55	1.15	2.53	0.92	0.23	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	35.97	1.05	2.52	0.21	0.21	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	24.46	1.43	1.63	0.41	0.00	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.97	1.07	2.57	0.43	1.50	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.34	1.56	0.22	0.67	0.00	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.13	0.66	2.63	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	0.51	1.01	0.51	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.65	1.63	1.36	0.54	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	30.88	0.59	1.47	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	46.13	2.88	2.88	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	38.02	0.00	3.60	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	51.06	1.50	6.51	0.00	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	67.44	1.75	4.82	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.33	1.28	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	78.84	1.98	6.69	0.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.70	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	56.07	2.39	4.44	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	1.75	0.88	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	0.71	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	65.09	1.12	6.45	0.84	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.30	0.00	2.49	0.42	1.25	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	0.58	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	45.85	0.60	4.22	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	55.10	1.67	3.34	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	0.92	3.69	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	40.41	1.14	3.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.48	0.69	2.63	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	54.94	1.04	5.70	0.26	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	33.46	0.43	1.72	0.43	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	28.02	0.00	1.60	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	36.52	0.30	2.69	0.00	0.30	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.85	1.13	0.42	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	55.10	0.96	7.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.91	0.88	2.87	0.00	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	0.76	1.14	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	44.89	1.70	4.83	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	53.09	0.98	4.18	0.25	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.93	2.06	1.76	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	44.69	0.58	3.75	0.29	0.29	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.15	1.65	2.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.65	0.89	2.08	0.00	1.19	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	0.00	3.77	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	1.78	3.56	0.00	3.56	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	52.57	0.99	3.29	0.99	2.30	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	0.00	1.05	1.05	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	66.42	1.38	1.38	0.99	1.19	1.98
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	59.60	3.73	1.86	4.66	2.79	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	52.57	1.88	2.63	1.50	0.38	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	42.35	1.33	1.07	1.07	0.00	2.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	60.85	2.15	2.38	0.68	0.79	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	34.63	0.74	2.95	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.74	0.37	1.83	1.47	0.37	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	1.56	0.00	1.56	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	76.42	1.60	5.88	0.53	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	1.01	2.02	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	40.48	0.42	4.22	0.84	0.84	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	1.36	0.00	8.17	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	73.75	1.91	4.45	2.54	0.00	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	44.54	1.62	7.29	3.24	1.62	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	1.51	4.53	3.02	0.00	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	11.42	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	0.00	6.52	9.79	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	4.75	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.10	3.66	1.29	1.51	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	52.26	2.09	2.09	1.05	0.00	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	30.70	2.00	0.00	0.00	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.19	5.01	0.42	0.83	0.42	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	45.44	5.51	0.76	0.19	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	3.19	1.60	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	4.08	0.00	0.00	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	49.62	5.51	5.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	37.67	0.84	1.67	0.42	0.42	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	38.82	4.65	2.56	0.46	0.23	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.05	1.89	0.54	0.00	0.27	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.64	2.73	1.47	0.21	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	11.13	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	41.20	0.99	1.99	1.49	0.50	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	49.26	3.79	2.17	0.00	0.27	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	37.63	2.49	2.04	0.00	0.91	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	30.70	3.27	0.16	0.16	0.16	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.56	2.37	0.91	0.18	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	45.62	3.18	1.06	0.00	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	46.22	3.60	1.80	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	71.21	4.92	1.64	0.00	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	30.41	1.14	0.49	0.49	0.65	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	33.51	2.47	1.76	0.71	0.18	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	48.52	3.52	0.70	0.00	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.05	4.60	0.92	0.00	0.46	3.22
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	39.85	7.71	1.29	0.32	0.32	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	70.01	2.07	0.34	0.00	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	80.91	5.06	2.53	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.62	2.90	0.45	0.45	0.45	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.83	2.12	0.85	0.85	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	27.77	1.66	0.95	0.47	0.95	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	45.50	5.15	2.15	0.43	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	180.56	36.11	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	28.32	2.67	0.67	0.33	1.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	1.35	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	29.36	1.98	0.79	0.00	0.00	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	1.86	2.79	0.93	0.93	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	38.22	3.78	1.51	0.76	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.18	0.65	0.65	0.98	0.65	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.97	1.74	0.44	0.00	0.87	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.42	2.71	0.90	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	1.76	0.00	2.65	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	45.21	4.65	0.66	0.00	1.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.70	4.96	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.59	2.68	0.00	1.15	0.77	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	56.25	5.44	0.60	0.00	0.30	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	30.94	0.44	1.11	0.22	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.75	4.07	1.36	0.00	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	40.85	4.27	0.00	1.22	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.63	1.26	0.00	0.31	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.66	2.72	1.21	0.91	0.30	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	33.23	4.75	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	54.41	3.40	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	10.12	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	53.05	5.96	2.61	0.50	0.62	0.50
Myoblast, donor2	11322-117D8	51.97	2.88	1.15	0.77	0.38	0.00
Myoblast, donor3	11398-118D3	51.29	4.04	2.35	0.67	0.50	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	48.89	2.77	1.02	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	88.56	8.61	4.92	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	69.06	7.54	3.32	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	57.06	6.99	6.81	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	52.26	3.63	6.53	3.99	2.18	0.36
Neural stem cells, donor2	11352-117H2	34.66	5.78	3.85	3.85	3.85	1.93
Neurons, donor1	11494-119E9	54.62	4.55	7.97	2.28	4.55	0.00
Neurons, donor2	11574-120E8	47.56	8.59	1.32	6.83	4.40	0.88
Neurons, donor3	11655-122E8	50.97	9.87	2.47	12.33	4.93	1.64
Neutrophils, donor1	11233-116C9	12.99	0.93	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	16.49	1.83	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	104.49	4.04	1.31	0.83	0.83	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	64.47	0.65	1.30	1.63	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	63.78	1.60	0.60	0.60	0.80	0.80
Olfactory epithelial cells, donor1	11933-125I7	51.07	2.06	1.65	0.14	0.41	0.41
Olfactory epithelial cells, donor2	11934-125I8	58.04	3.76	1.16	0.00	0.29	1.01
Olfactory epithelial cells, donor3	11935-125I9	45.52	3.41	1.82	1.93	0.57	0.45
Olfactory epithelial cells, donor4	11936-126A1	40.13	3.51	1.36	0.29	0.19	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	55.37	6.02	1.20	0.00	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	42.33	2.98	0.85	1.06	1.28	1.49
Osteoblast - differentiated, donor2	11353-117H3	41.15	3.43	2.29	6.86	0.00	5.72
Osteoblast - differentiated, donor3	11425-118G3	45.93	3.10	0.00	3.72	1.24	4.34
Osteoblast, donor1	11277-116H8	29.90	3.71	0.78	0.78	0.78	0.20
Osteoblast, donor2	11354-117H4	54.78	4.21	2.81	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	32.35	3.91	0.71	0.89	0.00	0.71
Pancreatic stromal cells, donor1	11249-116E7	55.34	5.81	2.11	0.51	0.34	0.34
Pericytes, donor1	11491-119E6	24.81	0.89	0.00	1.78	0.67	2.34
Pericytes, donor2	11571-120E5	42.10	2.04	0.00	0.68	0.68	1.81
Pericytes, donor3	11652-122E5	31.13	3.05	1.02	0.41	0.20	1.02
Perineurial Cells, donor1	11499-119F5	61.82	3.50	0.45	0.68	0.45	0.90
Perineurial Cells, donor2	11579-120F4	69.47	3.77	2.58	0.92	0.28	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	64.07	6.06	4.78	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	44.81	5.39	3.18	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	66.91	4.27	2.07	0.13	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	24.16	1.67	1.20	0.72	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	32.16	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	29.84	2.55	0.79	0.20	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	37.34	6.01	2.85	1.58	0.95	0.63
Preadipocyte - breast, donor1	11467-119B9	51.59	2.81	2.63	1.13	0.38	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	35.11	2.35	0.78	0.39	0.39	0.26
Preadipocyte - breast, donor2	11328-117E5	46.83	2.70	2.03	0.68	0.45	1.13
Preadipocyte - omental, donor1	11468-119C1	53.60	3.20	2.02	0.43	0.75	1.28
Preadipocyte - omental, donor2	11329-117E6	43.65	2.62	4.80	0.00	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	40.83	3.15	2.01	0.72	0.72	0.29
Preadipocyte - perirenal, donor1	11469-119C2	43.31	0.98	3.94	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	26.41	3.38	2.15	0.92	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	62.33	10.27	3.54	1.06	0.89	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	61.30	6.98	3.92	1.19	1.02	0.34
Preadipocyte - visceral, donor1	11280-116I2	75.26	8.48	2.51	0.47	0.93	0.47
Preadipocyte - visceral, donor2	11357-117H7	52.00	3.22	0.92	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	54.65	5.33	2.82	0.94	0.84	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	79.65	5.73	4.68	0.60	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	24.65	2.44	0.54	0.14	0.14	0.41
Prostate Epithelial Cells, donor3	11404-118D9	19.17	3.92	0.12	0.61	0.86	1.22
Prostate Stromal Cells, donor1	11254-116F3	57.52	6.95	4.67	0.34	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	59.53	5.74	1.61	0.18	0.72	0.54
Prostate Stromal Cells, donor3	11405-118E1	43.27	2.29	1.46	1.15	0.52	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	39.42	2.55	1.46	0.73	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	50.53	3.81	1.11	1.39	0.42	0.49
Renal Epithelial Cells, donor1	11517-119H5	14.20	1.52	1.01	2.54	1.52	0.51
Renal Epithelial Cells, donor2	11597-120H4	35.57	4.27	1.42	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	66.27	3.81	1.27	0.74	0.74	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	37.45	3.40	2.04	1.36	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	48.65	2.43	1.08	3.23	0.54	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.74	1.11	1.11	0.67	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	1.33	0.00	2.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	40.50	1.76	1.76	0.88	0.44	0.88
Renal Mesangial Cells, donor2	11598-120H5	53.29	3.13	1.25	1.25	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	18.86	1.66	0.28	0.83	1.94	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	75.96	6.98	1.61	0.27	1.07	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	43.86	3.37	0.00	0.84	0.00	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	41.08	4.24	1.35	0.39	0.96	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	59.38	6.74	0.26	0.78	0.78	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	62.82	0.85	1.99	0.85	0.57	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	28.82	3.09	0.00	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	64.23	2.51	0.75	0.75	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.43	6.41	2.54	2.00	0.67	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	42.88	3.57	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	40.73	5.50	3.30	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	3.48	2.32	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.47	2.34	0.78	0.52	0.39	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.19	3.48	1.29	0.70	0.40	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	49.19	6.92	2.23	1.23	0.45	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.65	4.34	4.09	0.62	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	33.68	5.71	1.75	0.47	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.90	5.08	3.24	1.39	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.14	3.01	1.51	0.68	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	27.53	4.24	2.57	0.00	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.42	4.84	2.51	0.18	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	39.74	1.72	1.72	0.29	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	31.66	4.61	2.15	0.64	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	39.83	3.54	2.66	0.66	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.53	1.72	1.15	0.38	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.43	4.75	1.68	0.37	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.89	3.95	1.32	0.75	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.73	1.33	2.26	0.40	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	30.08	5.16	2.04	0.49	0.49	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	35.90	4.96	2.67	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.76	2.24	1.60	0.53	0.32	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	27.47	5.61	3.36	0.56	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	29.57	3.59	1.37	0.34	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.07	1.82	1.09	0.55	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.66	5.15	1.96	0.12	0.37	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	37.07	5.10	3.63	0.40	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	43.40	1.42	2.12	0.00	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	33.33	4.96	1.98	0.40	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	33.21	3.27	2.34	0.94	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	38.78	1.24	1.66	1.04	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	27.43	4.87	3.10	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	30.08	1.88	2.09	0.42	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	35.66	2.96	2.42	1.08	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	17.88	3.24	1.87	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.83	3.66	2.12	0.77	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.42	1.89	2.06	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.22	3.02	1.37	1.23	0.82	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.73	5.58	3.45	1.48	0.49	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.61	1.19	1.53	0.51	1.02	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.51	3.55	2.22	1.63	0.15	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.06	3.20	1.33	0.80	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	28.48	0.97	2.07	0.55	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	31.91	5.00	1.67	0.48	0.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.42	3.83	0.81	1.01	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	43.04	3.11	1.79	0.75	0.28	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.09	2.45	1.75	0.35	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.39	1.51	2.72	1.51	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	42.71	2.08	2.08	0.73	0.24	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	42.21	6.70	4.08	2.62	1.02	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.76	4.26	1.22	0.00	1.83	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	45.21	3.01	0.90	0.60	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	29.86	2.49	1.81	1.13	1.58	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.95	3.59	1.50	1.20	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	41.68	2.48	3.78	1.53	0.71	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.89	2.56	2.35	1.49	1.28	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.65	3.61	1.20	1.80	3.00	0.60
Schwann Cells, donor1	11498-119F4	34.23	2.82	0.19	0.75	0.38	2.07
Schwann Cells, donor2	11578-120F3	44.23	13.61	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	42.50	3.29	1.31	0.00	0.44	0.22
Sebocyte, donor1	11220-116B5	42.18	2.19	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	17.92	2.76	0.00	0.00	0.46	0.46
Sebocyte, donor3	11378-118B1	27.62	2.27	0.82	0.00	0.41	0.82
Sertoli Cells, donor1	11255-116F4	59.64	8.28	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	36.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	57.54	3.61	0.97	0.97	0.62	0.44
Skeletal Muscle Cells, donor2	11358-117H8	12.29	3.61	1.45	2.17	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	40.97	4.18	1.67	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	72.73	5.18	0.94	0.16	0.47	1.10
Skeletal Muscle Cells, donor5	11455-119A6	82.05	4.46	1.19	0.59	0.45	0.59
Skeletal Muscle Cells, donor6	11459-119B1	75.57	5.23	1.69	0.92	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	82.28	5.29	2.77	1.13	1.39	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	66.35	4.42	0.86	1.57	0.14	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	74.21	8.04	1.09	0.40	0.79	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	52.91	4.38	1.26	0.17	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	22.44	7.96	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	30.00	1.51	0.69	0.41	0.69	0.96
Skin - palm, donor1	10286-104F7	21.49	5.37	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.76	2.74	1.59	0.86	0.29	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.98	2.45	2.45	7.36	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	32.98	2.86	2.21	0.39	0.52	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	41.01	5.14	2.36	0.83	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	22.08	2.53	0.98	1.27	0.70	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	43.56	3.81	3.17	2.33	2.33	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	16.26	3.60	0.22	1.87	0.67	1.20
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	44.74	1.85	0.93	0.00	0.00	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.01	0.89	0.67	0.00	0.22	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	2.35	0.59	0.00	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	33.37	1.99	1.77	0.44	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.05	1.58	1.18	0.79	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	1.55	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	70.05	2.00	2.00	1.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.03	1.86	0.53	0.13	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	50.54	5.10	0.89	0.66	0.44	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.67	2.43	1.66	0.38	0.38	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	50.47	3.26	0.98	0.33	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	51.68	5.02	0.59	1.48	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.46	2.56	0.71	0.71	0.85	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	35.46	4.23	0.49	0.33	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	44.14	3.04	0.61	0.00	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	52.28	5.81	0.51	0.00	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.46	2.38	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	47.34	3.98	0.88	0.29	0.59	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	49.07	3.01	0.86	0.65	0.00	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	44.50	3.88	1.47	0.21	0.31	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.64	0.93	1.39	0.31	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	2.16	0.00	0.00	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.60	3.29	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.85	1.37	1.02	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	42.88	2.83	1.18	0.94	0.86	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	39.25	2.92	1.21	0.40	0.70	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	60.53	5.92	4.10	0.46	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	1.81	0.00	0.00	0.60	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	82.13	10.33	1.59	0.53	0.00	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	76.83	2.93	3.20	1.86	0.53	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	48.33	2.25	2.00	0.25	0.13	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	59.61	3.55	1.01	0.25	0.25	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	53.83	3.77	2.26	0.15	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	37.51	2.25	2.25	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	1.29	1.29	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	1.86	3.26	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	28.78	3.03	1.51	0.50	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	32.59	2.82	0.94	0.31	0.00	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.60	1.18	0.29	1.18	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	46.32	3.58	1.58	1.17	0.50	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	40.64	0.93	0.93	0.00	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.13	1.44	0.86	0.43	0.00	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	28.05	2.55	1.02	0.25	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.77	2.44	0.56	0.38	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	70.57	5.45	1.12	0.42	0.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	54.80	2.93	0.84	0.42	0.08	1.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.81	1.90	0.00	0.00	0.00	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.10	2.94	0.49	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	44.63	1.99	1.33	1.77	0.66	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	61.15	6.14	1.17	1.17	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	45.09	4.08	1.36	0.58	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.10	1.59	0.53	1.06	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	79.22	2.23	1.49	0.00	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	51.03	3.95	2.16	0.00	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.81	1.70	0.85	0.00	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	50.42	3.94	3.15	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	40.38	1.78	1.52	0.25	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	52.71	1.20	0.80	0.00	0.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	40.96	3.76	1.67	0.42	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	60.05	2.29	1.38	0.00	1.83	1.38
Synoviocyte, donor1	11291-117A4	42.59	2.69	0.84	1.51	0.34	0.17
Synoviocyte, donor2	11368-117I9	75.77	4.36	2.18	0.50	1.84	1.84
Synoviocyte, donor3	11440-118H9	79.98	4.02	1.56	0.89	1.12	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	45.02	4.29	0.00	0.00	0.71	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.12	1.39	0.00	0.46	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	26.02	2.80	0.86	1.22	0.50	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	26.67	2.32	0.39	1.16	0.00	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	28.06	2.29	2.29	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	40.11	4.80	1.48	0.49	0.37	0.37
Urethra, donor2	10319-105A4	19.78	7.19	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	29.75	2.66	0.00	0.00	0.27	0.53
Urothelial Cells, donor2	11600-120H7	23.23	1.60	0.40	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	21.55	2.06	0.00	0.00	0.46	0.46
Urothelial cells, donor0	11216-116B1	51.49	6.24	0.67	0.45	0.67	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	72.96	2.67	3.56	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	2.86	2.86	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.91	2.74	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	63.70	7.23	1.72	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	67.40	4.07	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	53.10	0.00	1.04	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	75.26	2.75	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	39.25	6.39	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	56.99	3.21	1.11	3.58	2.47	2.10
Wilms' tumor cell line:HFWT	10597-108E3	14.96	3.52	0.00	7.04	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	45.81	8.38	0.84	0.00	0.00	0.56
achilles tendon, donor2	10292-104G4	20.67	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	116.77	5.35	3.31	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	128.16	10.45	6.50	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	99.83	10.80	2.49	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	111.57	5.71	4.35	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	95.29	5.62	5.62	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	179.76	7.61	6.56	0.63	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.99	2.18	2.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	125.14	3.53	3.53	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	91.88	3.68	3.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	118.82	6.99	7.38	2.72	2.72	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	125.30	8.46	3.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	82.03	2.56	3.95	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	108.48	10.36	4.14	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	90.30	6.72	4.38	0.00	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.45	2.32	2.32	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	81.02	5.76	2.06	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	29.16	4.60	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	107.96	5.97	2.99	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	90.68	7.89	4.55	0.00	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	108.56	5.78	2.41	0.00	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	73.95	5.79	1.34	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	60.71	3.67	1.67	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	3.72	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	85.13	3.39	1.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	69.78	5.67	1.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	16.87	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	61.23	8.24	1.41	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	47.62	4.03	1.24	0.00	0.31	0.47
adipose, donor1	10184-103D4	131.94	9.97	6.45	0.59	1.17	0.00
adipose, donor2	10185-103D5	43.80	4.87	0.81	7.70	2.43	2.43
adipose, donor3	10186-103D6	43.02	6.53	2.72	3.81	4.08	1.63
adipose, donor4	10187-103D7	62.41	5.20	3.47	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	29.04	3.95	0.16	0.16	1.10	2.21
adrenal gland, adult, pool1	10081-102A9	25.46	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	72.17	7.34	2.13	0.13	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	33.23	4.64	0.36	0.36	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	33.62	6.96	1.16	0.46	0.70	1.39
amniotic membrane cells, donor2	12236-129G4	66.94	11.83	1.01	0.00	0.34	1.35
amniotic membrane cells, donor3	12237-129G5	37.12	3.83	0.29	0.29	0.29	0.59
amygdala - adult, donor10196	10167-103B5	29.64	2.37	3.56	3.56	1.19	5.93
amygdala, adult, donor10252	10151-102I7	24.74	5.68	1.22	5.47	6.08	4.46
amygdala, newborn, donor10223	10360-105E9	34.21	6.78	0.65	2.26	1.94	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	137.13	7.00	1.53	0.25	0.64	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	76.34	8.38	1.32	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	57.79	2.67	1.34	2.00	2.67	0.67
aorta, adult, pool1	10052-101G7	42.36	6.47	0.59	1.18	1.77	2.75
appendix, adult	10189-103D9	45.02	5.05	0.39	0.39	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	224.59	7.91	4.47	1.03	0.34	0.69
artery, adult	10190-103E1	27.17	2.72	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	79.68	5.22	5.07	0.43	0.72	0.00
b cell line:RPMI1788	10427-106D4	94.13	2.97	1.64	0.30	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	44.11	4.44	2.50	0.00	0.55	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	49.32	6.35	1.29	0.99	0.20	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	20.59	3.35	0.17	1.00	0.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	128.62	1.68	7.83	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	47.04	6.63	0.98	0.76	0.43	0.76
blood, adult, pool1	10053-101G8	37.65	4.43	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	30.83	4.28	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	66.13	6.07	1.35	0.00	1.35	0.00
brain, adult, donor1	10084-102B3	29.73	7.18	1.03	2.05	1.03	2.05
brain, adult, pool1	10012-101C3	36.41	5.12	1.11	2.56	2.78	3.01
brain, fetal, pool1	10085-102B4	56.10	8.01	2.67	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.03	1.65	0.66	3.96	0.66	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	46.56	7.74	1.37	0.00	0.62	0.37
breast, adult, donor1	10080-102A8	34.09	5.05	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	50.18	3.81	1.02	0.25	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	50.09	8.04	1.86	3.71	1.86	3.40
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	96.46	13.81	0.46	0.00	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	54.95	6.78	0.97	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	74.29	7.99	2.35	0.47	0.00	2.35
carcinoid cell line:NCI-H727	10735-110B6	46.05	7.00	1.42	1.97	0.66	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	31.69	4.44	0.95	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	93.43	8.25	2.40	1.60	1.60	1.06
caudate nucleus - adult, donor10196	10177-103C6	33.39	3.45	1.15	1.15	1.15	4.61
caudate nucleus, adult, donor10252	10164-103B2	36.98	4.35	1.00	3.18	2.01	2.01
caudate nucleus, adult, donor10258	10379-105H1	45.85	3.82	0.76	0.00	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	33.69	3.30	1.83	2.56	0.37	1.83
cerebellum - adult, donor10196	10173-103C2	72.83	2.91	0.00	2.91	8.74	5.83
cerebellum, adult, donor10252	10166-103B4	59.57	11.53	0.64	4.91	8.75	5.76
cerebellum, adult, pool1	10083-102B2	51.40	8.62	2.07	0.00	3.79	4.14
cerebellum, newborn, donor10223	10357-105E6	81.37	9.96	4.98	4.15	6.64	0.00
cerebral meninges, adult	10188-103D8	17.40	4.03	0.25	5.04	2.52	2.02
cerebrospinal fluid, donor2	10294-104G6	10.23	1.46	0.73	0.00	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	114.45	11.65	1.29	0.43	0.58	0.72
cervical cancer cell line:ME-180	10553-107I4	52.53	5.30	0.83	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	43.26	7.14	0.84	2.31	1.26	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	127.91	14.21	3.90	1.53	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	89.73	8.08	1.37	0.00	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	56.43	5.54	0.25	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	24.90	3.56	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	42.74	4.27	1.42	0.00	0.57	1.71
chorionic membrane cells, donor2	12239-129G7	54.99	6.07	2.59	0.60	0.00	0.50
chorionic membrane cells, donor3	12240-129G8	46.71	2.20	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	104.01	10.10	3.03	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	83.75	5.76	1.92	0.38	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	56.81	3.80	2.96	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	52.39	8.99	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	45.47	8.22	0.48	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	46.22	8.35	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	122.49	15.61	1.77	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	101.64	5.47	3.13	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	46.17	5.71	0.23	1.60	0.91	2.74
clear cell carcinoma cell line:TEN	10636-108I6	137.07	9.89	4.16	1.39	0.35	1.21
colon carcinoma cell line:CACO-2	10513-107D9	153.21	6.59	7.50	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	60.81	7.98	0.76	0.38	0.38	0.38
colon, adult, donor1	10082-102B1	67.83	9.52	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	43.48	4.11	0.59	0.59	0.59	0.35
colon, fetal, donor1	10070-101I7	48.20	5.56	0.62	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	41.25	13.75	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	89.24	8.07	3.40	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	101.58	4.53	2.41	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	107.17	6.91	3.95	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	46.22	5.42	1.77	2.87	2.43	2.43
cruciate ligament, donor2	10295-104G7	22.69	2.43	0.81	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	21.67	4.01	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	30.24	3.36	0.72	1.44	1.44	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	75.77	4.13	5.28	0.00	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	108.22	17.95	1.54	0.77	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	57.53	1.44	7.70	3.37	1.93	1.69
ductus deferens, adult	10196-103E7	25.91	7.97	0.00	1.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	74.89	4.32	0.00	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	72.83	9.56	0.00	0.74	0.74	0.74
dura mater, adult, donor1	10041-101F5	75.07	6.94	1.49	0.83	0.58	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	51.52	6.66	9.33	0.89	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	54.74	6.30	4.01	0.86	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	38.23	3.08	0.62	3.08	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	63.27	7.57	0.00	1.21	0.30	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	44.77	5.87	0.62	0.31	1.23	0.93
embryonic pancreas cell line:2C6	10603-108E9	42.03	3.94	0.00	2.63	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	79.11	7.71	3.02	4.69	1.34	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	71.41	10.51	1.63	2.17	1.63	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	41.81	5.47	1.45	0.00	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	39.02	5.00	1.33	0.11	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	74.90	12.32	3.96	0.00	0.00	0.11
epididymis, adult	10197-103E8	38.72	5.86	1.47	1.26	0.63	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	57.66	7.10	0.53	3.37	2.31	2.31
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	34.61	2.36	0.79	6.69	2.36	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	81.25	9.04	3.67	0.66	0.66	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	89.96	9.05	4.13	1.57	0.49	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	71.59	9.52	3.02	0.90	0.67	0.45
esophagus, adult, pool1	10015-101C6	51.92	8.18	1.06	0.42	0.00	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	37.57	3.26	0.38	5.76	2.25	0.63
eye - muscle inferior rectus, donor1	10272-104E2	12.07	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	14.88	2.98	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	17.20	3.44	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	0.00	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	40.42	4.07	0.25	1.02	0.51	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	63.86	5.39	0.64	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	41.31	5.94	0.71	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	44.47	5.54	1.31	3.75	2.63	3.85
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	159.13	17.11	5.10	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	54.22	7.86	0.91	0.37	0.27	0.91
gall bladder, adult	10198-103E9	54.08	5.07	1.45	0.72	0.72	1.93
gamma delta positive T cells, donor1	11937-126A2	84.29	7.52	5.37	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	87.77	7.84	2.99	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	54.28	5.49	1.06	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	39.07	4.45	0.19	3.29	1.55	1.16
gastric cancer cell line:AZ521	10549-107H9	66.24	7.38	2.79	2.62	1.48	0.98
gastric cancer cell line:GSS	10560-108A2	74.13	9.15	0.92	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	51.63	2.74	1.37	2.74	0.46	1.60
giant cell carcinoma cell line:LU65	10487-107B1	82.96	11.93	1.15	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	54.58	4.06	0.42	0.98	0.56	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.19	5.49	0.00	0.25	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.10	5.17	0.95	0.00	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	40.59	6.46	1.40	0.00	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	52.54	4.75	1.66	0.33	0.33	0.22
glioma cell line:GI-1	10413-106B8	83.47	7.32	3.51	0.88	0.59	1.17
globus pallidus - adult, donor10196	10175-103C4	37.17	0.73	0.00	2.92	0.73	3.64
globus pallidus, adult, donor10252	10161-103A8	40.52	4.15	0.49	5.13	2.93	2.69
globus pallidus, adult, donor10258	10367-105F7	20.54	4.11	0.00	5.48	1.37	4.11
globus pallidus, newborn, donor10223	10364-105F4	37.84	2.13	0.53	1.07	2.13	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	2.45	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	5.23	10.45	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	29.44	2.56	0.00	0.00	0.32	0.96
hIPS +CCl2, biol_rep1	14383-156B9	95.95	1.84	5.51	3.67	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	75.45	1.37	4.57	1.83	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	76.00	1.93	5.15	1.93	0.00	0.00
hIPS, biol_rep1	14380-156B6	71.86	2.87	7.19	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	63.79	4.80	2.74	2.06	0.00	2.06
hIPS, biol_rep3	14382-156B8	32.00	3.31	0.00	2.21	3.31	2.21
hairy cell leukemia cell line:Mo	10712-109I1	68.68	4.02	1.44	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	31.39	5.08	0.30	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	27.72	3.66	0.00	0.78	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	25.81	5.83	0.00	0.00	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	38.97	5.31	1.22	0.20	0.41	1.02
heart, adult, diseased, donor1	10051-101G6	22.57	6.39	0.00	0.00	0.00	0.85
heart, adult, pool1	10016-101C7	14.95	3.22	0.23	0.46	0.46	0.92
heart, fetal, pool1	10046-101G1	51.65	6.26	0.82	0.82	1.13	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	17.59	2.16	0.93	0.00	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	69.06	2.87	3.98	0.22	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	74.52	3.03	3.40	0.12	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	80.03	3.64	3.64	0.10	0.10	0.30
hepatoma cell line:Li-7	10484-107A7	68.18	9.01	1.89	1.11	0.11	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	97.49	6.53	3.72	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	29.34	4.73	0.00	1.89	0.95	2.84
hippocampus, adult, donor10252	10153-102I9	32.45	5.10	0.61	5.71	4.29	3.88
hippocampus, adult, donor10258	10374-105G5	22.41	1.49	0.00	2.49	1.00	3.98
hippocampus, newborn, donor10223	10363-105F3	30.67	2.47	1.41	2.47	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	145.26	16.48	6.71	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	95.43	6.28	2.36	0.98	0.39	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	107.14	5.33	5.84	1.78	0.76	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	68.79	3.38	2.82	1.13	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	63.00	3.87	1.55	1.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	69.47	6.07	2.28	0.38	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	45.54	4.67	2.04	4.38	2.63	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.64	5.17	1.51	4.52	1.94	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	1.67	2.09	4.17	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	73.88	5.92	4.26	3.55	2.84	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	55.45	5.46	2.25	3.86	2.89	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	80.80	6.73	2.69	5.39	3.37	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	79.34	3.91	4.85	3.29	0.94	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	84.50	5.90	4.42	3.44	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	166.70	7.85	9.60	2.62	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	68.16	7.45	1.34	1.91	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.92	5.67	0.87	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	75.96	10.00	2.50	0.00	1.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	45.21	4.14	0.94	4.52	2.64	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.39	2.73	1.36	4.55	4.09	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	56.38	3.45	0.63	5.64	1.57	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	45.72	4.25	1.14	3.27	2.78	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.42	4.06	0.87	2.32	2.03	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.32	4.48	1.20	3.59	4.48	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	86.28	4.43	4.43	1.66	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	76.74	6.28	3.99	2.57	1.43	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	124.94	7.76	6.12	3.27	2.04	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	61.26	4.58	1.06	0.35	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	57.96	8.24	2.22	1.27	0.95	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	62.64	4.24	3.03	1.21	0.91	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	55.33	3.62	1.03	4.65	2.07	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	50.48	6.64	1.33	1.33	0.66	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	41.56	4.10	0.51	3.33	3.08	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.39	3.83	2.30	1.79	2.05	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.16	8.33	0.76	6.82	2.27	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	55.79	4.70	1.68	4.03	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	91.77	4.59	3.62	1.93	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	96.26	4.46	6.24	2.67	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	99.51	6.34	2.93	4.39	0.98	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	64.79	3.97	0.92	2.14	0.31	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	234.23	26.03	19.52	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	99.61	5.30	3.31	1.65	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	60.75	6.57	0.55	4.93	2.19	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	55.01	4.70	0.72	9.41	2.53	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.20	3.56	1.07	11.03	4.63	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	57.28	1.19	2.39	7.16	3.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	60.26	4.47	1.63	6.91	5.28	2.84
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	48.76	5.12	1.08	7.27	3.50	1.89
immature langerhans cells, donor1	11904-125F5	68.04	4.60	6.54	0.00	0.24	0.24
immature langerhans cells, donor2	11905-125F6	58.62	4.75	2.38	0.79	0.79	3.96
insula, adult, pool1	10039-101F3	40.60	4.07	1.61	4.16	3.50	2.84
keratoacanthoma cell line:HKA-1	10791-110H8	47.47	5.53	1.63	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	52.77	6.81	1.60	1.80	1.00	0.20
kidney, fetal, pool1	10045-101F9	44.63	5.52	1.49	2.97	1.13	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.33	2.27	1.42	3.27	0.85	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.38	3.46	1.11	0.55	0.28	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	34.86	6.61	0.92	0.73	0.55	0.92
left atrium, adult, donor1	10079-102A7	34.87	4.90	0.54	0.54	0.00	1.63
left ventricle, adult, donor1	10078-102A6	34.38	7.08	1.01	0.51	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	32.01	4.92	0.82	2.19	1.37	0.27
leiomyoma cell line:10964C	10569-108B2	43.11	2.16	3.23	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	38.04	1.63	3.80	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	45.41	4.13	1.94	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	2.09	1.05	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	112.86	4.25	5.55	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	50.14	5.15	0.62	2.50	0.62	0.94
liposarcoma cell line:SW 872	10726-110A6	33.99	4.26	1.83	0.97	0.37	0.61
liver, adult, pool1	10018-101C9	48.46	6.48	1.30	0.65	0.00	0.00
liver, fetal, pool1	10086-102B5	28.22	1.88	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.81	3.65	0.73	1.60	1.90	3.06
locus coeruleus, adult, donor10252	10165-103B3	34.33	3.51	0.74	5.17	2.95	4.80
locus coeruleus, adult, donor10258	10375-105G6	33.86	3.95	1.41	4.51	3.67	4.80
locus coeruleus, newborn, donor10223	10362-105F2	56.36	2.94	0.42	0.84	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	25.05	2.08	0.55	0.69	0.28	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	57.22	6.20	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.86	6.59	0.79	3.16	1.85	1.98
lung, adult, pool1	10019-101D1	33.55	3.43	0.71	1.06	1.30	0.47
lung, fetal, donor1	10068-101I5	66.21	2.85	2.28	1.43	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	48.57	7.79	1.37	3.21	1.83	0.46
lymph node, adult, donor1	10077-102A5	42.60	6.63	1.42	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	58.96	3.73	2.63	1.32	0.66	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	138.10	6.34	6.34	2.57	1.51	2.41
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	5.10	4.25	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	38.63	8.44	0.44	0.89	0.44	1.78
mature adipocyte, donor2	12232-129F9	42.54	5.40	1.66	0.42	0.21	1.04
mature adipocyte, donor3	12233-129G1	54.76	7.59	1.66	0.47	0.00	0.47
mature adipocyte, donor4	12234-129G2	71.60	7.90	2.90	1.58	0.79	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	62.90	8.82	0.95	1.19	0.00	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	39.48	6.77	0.00	1.13	3.38	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	29.79	2.94	0.55	4.41	3.68	3.86
medial frontal gyrus, adult, donor10258	10368-105F8	40.66	4.45	1.59	2.54	3.49	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	45.63	5.97	3.84	3.41	0.85	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	35.44	7.43	1.18	2.70	1.86	6.41
medial temporal gyrus, adult, donor10252	10156-103A3	28.65	4.24	1.06	4.24	4.24	5.09
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	0.00	0.00	3.85	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	46.66	3.23	0.72	3.23	2.87	0.72
medulla oblongata - adult, donor10196	10174-103C3	28.56	6.49	0.65	0.65	1.95	1.30
medulla oblongata, adult, donor10252	10155-103A2	34.68	3.87	0.77	4.49	2.32	3.72
medulla oblongata, adult, pool1	10038-101F2	38.36	3.10	1.39	2.86	2.45	1.88
medulla oblongata, newborn, donor10223	10361-105F1	38.54	3.47	0.00	2.43	2.78	1.04
medulloblastoma cell line:D283 Med	10838-111E1	52.03	4.87	0.89	0.44	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	28.61	3.18	0.86	0.12	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	27.02	2.16	1.29	1.87	0.72	0.72
melanoma cell line:G-361	10465-106H6	43.43	6.24	0.81	3.80	1.09	2.44
meningioma cell line:HKBMM	10691-109F7	40.34	4.70	0.36	0.36	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	110.14	14.10	2.64	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	74.40	10.89	1.81	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	86.84	7.67	2.15	0.31	0.31	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	66.17	4.73	0.73	0.91	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	70.81	1.24	1.24	0.41	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	57.88	2.67	2.11	0.14	0.00	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	59.50	5.01	1.93	0.39	0.39	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	72.18	1.39	4.16	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.41	2.23	1.72	0.69	0.00	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	57.16	3.57	2.76	0.23	0.23	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	69.10	4.11	3.18	0.00	0.66	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.50	7.70	2.84	0.14	0.14	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	41.83	3.41	2.28	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.80	1.65	1.65	0.66	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	49.26	4.84	1.38	0.14	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	49.57	4.89	2.09	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	45.32	3.47	0.61	0.20	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	33.79	1.44	1.44	0.36	0.36	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.07	3.21	0.83	0.00	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.57	2.05	2.96	0.91	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	82.65	2.52	4.62	0.84	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	43.64	2.69	1.79	0.30	0.45	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	46.74	3.50	1.31	0.35	0.35	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.56	1.47	1.84	0.74	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	30.62	2.29	3.15	0.00	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	64.84	7.58	1.68	0.84	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	70.33	4.11	0.46	1.37	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	59.09	3.07	1.53	0.26	0.77	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	64.13	4.71	3.14	1.05	1.05	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	55.76	3.70	1.23	0.62	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	63.55	4.00	2.35	1.18	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.18	5.08	2.37	0.68	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	66.41	2.75	2.36	0.79	0.39	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	60.24	3.24	0.93	2.32	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	64.89	3.46	2.60	1.73	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	62.02	2.68	3.35	0.22	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	67.54	3.85	1.44	0.48	0.48	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	49.87	4.40	5.13	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.40	2.69	2.69	0.67	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	67.96	4.50	2.05	0.82	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	58.85	3.01	2.15	1.29	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	73.83	2.73	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	10.33	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	67.23	5.85	1.95	0.65	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	4.36	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	59.17	5.33	3.20	0.53	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	64.60	3.27	2.45	3.27	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	52.87	1.17	1.94	0.78	0.78	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	73.46	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	58.61	1.99	3.97	0.99	1.99	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	63.45	2.96	3.56	0.59	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	54.83	8.53	3.66	1.22	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	63.34	1.90	1.90	0.63	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	81.05	2.41	3.79	1.03	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	0.00	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	80.68	2.04	2.85	0.00	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	86.59	4.77	1.59	1.59	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	68.97	2.36	1.18	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	69.82	4.05	1.56	0.31	0.31	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	76.19	2.67	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	57.95	2.37	2.37	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	64.71	6.20	0.69	2.07	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	54.92	2.97	1.98	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	2.24	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	48.98	1.91	2.54	1.91	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	40.70	4.43	1.61	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	0.00	2.18	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	30.41	3.80	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.05	4.25	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.07	3.29	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.75	5.56	1.19	0.60	0.99	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	45.43	3.57	0.97	0.97	0.97	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	66.21	1.02	3.06	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.95	2.32	0.00	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	48.90	9.69	0.94	1.65	0.94	4.96
mesothelioma cell line:ACC-MESO-4	10494-107B8	51.43	4.63	2.09	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	8.55	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	126.69	8.94	4.93	0.10	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	27.92	2.50	2.04	2.95	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	33.25	3.67	0.24	0.24	1.22	0.98
mesothelioma cell line:Mero-48a	10852-111F6	24.58	1.99	0.66	0.00	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	57.29	5.52	3.42	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	55.83	3.57	2.72	0.17	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	31.60	2.02	0.51	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	55.49	2.28	1.24	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	44.39	4.80	1.33	0.66	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	68.78	3.08	2.90	0.00	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	89.68	7.69	1.37	0.00	0.00	0.51
mesothelioma cell line:NCI-H28	10845-111E8	46.06	3.56	1.02	2.04	0.51	0.76
mesothelioma cell line:No36	10857-111G2	32.95	3.26	1.96	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	24.39	2.44	3.52	1.35	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	69.48	3.84	1.73	0.58	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	42.25	3.05	1.10	0.37	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	70.18	2.51	2.15	0.54	0.72	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	24.16	4.24	0.33	0.00	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	46.41	3.18	3.81	0.64	0.21	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	66.11	9.44	1.15	2.30	0.69	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	65.84	5.71	2.47	0.00	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	253.17	13.31	1.48	0.00	0.37	0.18
myeloma cell line:PCM6	10474-106I6	68.39	4.15	0.59	0.00	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	19.78	3.04	1.01	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	62.18	7.85	0.59	0.00	0.39	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	27.97	4.35	0.33	1.23	0.89	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.52	6.84	0.44	1.99	0.74	1.40
nasal epithelial cells, donor2	12227-129F4	24.29	2.76	0.55	1.10	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	60.74	7.13	0.46	1.84	0.69	0.92
neuroblastoma cell line:NB-1	10539-107G8	55.56	6.36	2.25	2.99	1.87	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	33.11	5.27	0.42	0.84	0.42	1.27
neuroblastoma cell line:NH-12	10555-107I6	94.11	8.20	1.12	0.75	2.61	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	63.34	5.69	0.24	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	48.46	8.55	0.79	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	79.70	4.43	0.60	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.34	6.99	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	36.20	3.73	1.06	0.00	0.27	1.06
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	218.67	10.49	6.93	1.18	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	54.43	13.61	8.01	3.20	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.28	4.49	1.60	0.32	0.64	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	60.96	3.68	2.10	0.79	0.00	1.05
nucleus accumbens, adult, pool1	10037-101F1	41.81	5.44	1.22	2.81	1.69	2.44
occipital cortex - adult, donor10196	10172-103C1	55.63	8.24	0.00	2.06	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	33.55	4.03	0.27	4.83	4.29	2.68
occipital cortex, newborn, donor10223	10355-105E4	27.30	4.37	1.09	0.73	2.55	0.73
occipital lobe, adult, donor1	10076-102A4	37.79	6.82	0.52	2.36	2.62	4.72
occipital lobe, fetal, donor1	10073-102A1	56.64	10.30	0.86	6.01	7.29	6.01
occipital pole, adult, pool1	10036-101E9	31.38	3.23	0.55	1.73	1.26	1.58
olfactory region, adult	10195-103E6	25.79	3.82	0.38	2.10	1.91	3.82
optic nerve, donor1	10277-104E7	36.02	0.00	0.00	2.00	2.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	23.01	2.05	0.57	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	66.50	4.53	0.69	0.27	0.27	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.35	3.73	1.19	0.17	0.00	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	41.24	3.35	1.04	0.35	0.58	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	42.04	4.70	1.18	0.00	0.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	72.88	7.47	1.87	0.00	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.27	2.97	0.64	0.00	0.85	0.42
ovary, adult, pool1	10020-101D2	45.60	5.77	1.57	0.79	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.32	3.85	0.18	0.00	0.18	1.47
pancreas, adult, donor1	10049-101G4	52.68	8.47	1.88	0.94	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	52.83	6.71	0.84	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	53.83	6.64	1.87	1.87	1.36	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.37	1.82	0.50	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	37.16	5.22	0.82	2.01	1.92	4.94
parietal cortex, adult, donor10258	10373-105G4	32.30	2.20	0.73	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	31.04	8.46	0.94	3.76	3.76	3.76
parietal lobe, adult, donor10252	10157-103A4	25.94	4.28	0.86	5.70	3.14	5.13
parietal lobe, adult, pool1	10034-101E7	35.16	5.02	0.97	2.56	1.67	4.76
parietal lobe, fetal, donor1	10072-101I9	52.37	5.82	0.00	8.73	4.85	5.82
parietal lobe, newborn, donor10223	10356-105E5	27.67	6.36	0.75	3.36	2.24	1.12
parotid gland, adult	10199-103F1	29.60	5.55	0.62	0.62	0.00	0.62
penis, adult	10200-103F2	40.82	7.52	2.15	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	70.47	9.11	0.37	0.00	0.37	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.32	2.77	0.58	1.02	1.02	0.73
pineal gland - adult, donor10196	10179-103C8	23.22	1.94	1.29	0.00	1.29	2.58
pineal gland, adult, donor10252	10160-103A7	49.75	2.96	0.59	1.18	2.96	2.37
pineal gland, adult, donor10258	10377-105G8	35.74	3.76	1.25	3.76	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	41.48	2.02	1.01	1.01	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	74.01	4.69	3.13	2.08	3.65	2.61
pituitary gland, adult, donor10258	10378-105G9	67.25	9.36	2.55	3.40	1.70	1.70
placenta, adult, pool1	10021-101D3	42.57	6.24	1.94	0.11	0.32	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	66.48	5.43	1.72	0.13	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.60	9.81	0.62	0.00	0.00	0.31
pons, adult, pool1	10033-101E6	34.86	3.10	0.86	2.58	2.24	3.10
postcentral gyrus, adult, pool1	10032-101E5	36.96	4.97	0.61	2.01	2.44	2.62
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	11.02	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	11.74	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	119.73	15.29	2.77	1.75	0.73	1.60
prostate cancer cell line:PC-3	10439-106E7	80.04	13.07	1.63	5.63	2.36	0.91
prostate, adult, pool1	10022-101D4	44.26	6.35	1.00	0.82	0.54	1.09
putamen, adult, donor10196	10176-103C5	33.28	6.14	0.71	2.36	0.71	1.65
putamen, adult, donor10252	10152-102I8	21.57	7.84	1.96	3.92	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	2.19	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	27.54	4.35	0.72	2.17	1.69	1.45
putamen, newborn, donor10223	10365-105F5	53.23	6.75	0.75	0.75	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	43.64	2.33	1.75	1.16	0.00	0.00
rectum, fetal, donor1	10067-101I4	63.99	11.13	1.39	1.39	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	23.74	3.39	0.00	2.54	1.91	3.60
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	49.71	4.14	0.83	4.14	1.24	2.49
retina, adult, pool1	10030-101E3	40.55	7.65	0.70	1.49	1.69	0.89
retinoblastoma cell line:Y79	10475-106I7	121.07	14.81	2.60	7.27	2.08	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.29	2.83	0.98	0.49	0.37	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	63.27	6.75	1.12	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	33.35	3.03	0.00	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	51.96	1.46	0.81	0.16	0.00	0.32
salivary acinar cells, donor2	11772-123I8	38.55	3.17	0.28	0.41	0.28	0.83
salivary acinar cells, donor3	11773-123I9	11.25	1.32	0.00	1.32	0.66	0.66
salivary gland, adult, pool1	10093-102C3	59.48	2.86	0.00	2.29	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	103.87	5.14	0.51	2.19	1.18	1.18
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	99.57	4.82	0.94	1.76	1.06	2.59
seminal vesicle, adult	10201-103F3	29.10	5.82	0.53	1.06	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	46.40	4.86	3.16	0.97	0.49	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	31.71	5.79	2.26	1.76	1.01	3.27
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	77.27	11.04	1.00	2.01	2.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.04	2.96	0.54	0.27	0.54	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	63.77	6.08	0.77	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	58.32	2.97	1.81	1.03	0.65	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	18.44	4.97	0.71	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	37.30	5.88	0.48	0.36	0.36	0.12
skeletal muscle, fetal, donor1	10066-101I3	37.19	2.01	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	74.64	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	49.87	10.73	0.63	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.35	4.34	1.00	1.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	88.89	5.36	2.84	1.26	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	38.74	9.64	0.77	0.39	0.39	4.05
small cell lung carcinoma cell line:LK-2	10541-107H1	27.03	3.46	0.33	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	69.81	11.10	0.32	3.54	1.13	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	78.45	8.28	7.19	17.00	5.23	4.36
small intestine, adult, pool1	10024-101D6	56.85	8.96	1.19	0.00	0.12	0.12
small intestine, fetal, donor1	10064-101I1	58.97	5.16	2.46	0.98	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.62	7.18	1.54	1.03	1.03	1.54
smooth muscle, adult, pool1	10048-101G3	43.68	6.46	0.78	1.03	1.55	1.81
somatostatinoma cell line:QGP-1	10781-110G7	17.69	4.29	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	36.93	4.36	0.23	2.52	0.92	4.36
spinal cord, adult, donor10252	10159-103A6	44.95	3.55	0.39	4.34	2.37	0.79
spinal cord, adult, donor10258	10369-105F9	43.58	4.84	0.69	3.46	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	47.57	3.05	1.22	1.83	2.44	2.44
spinal cord, newborn, donor10223	10359-105E8	49.59	5.51	2.30	3.67	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.08	3.58	1.64	0.30	0.00	0.45
spleen, adult, pool1	10025-101D7	47.03	3.52	1.54	0.00	0.22	0.44
spleen, fetal, pool1	10044-101F8	47.28	4.77	1.19	0.56	0.16	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.07	2.69	4.14	2.38	1.35	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	59.43	8.16	4.18	1.52	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	57.66	5.94	2.45	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	43.39	2.74	1.56	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	94.55	10.24	7.32	2.48	0.68	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	38.97	4.24	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	187.00	20.73	3.81	3.81	2.54	1.69
stomach, fetal, donor1	10062-101H8	33.11	5.34	0.00	0.00	1.07	1.07
submaxillary gland, adult	10202-103F4	36.46	4.56	0.00	1.14	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	35.52	3.95	0.83	5.82	2.70	2.70
substantia nigra, adult, donor10258	10371-105G2	27.41	2.07	0.52	1.03	1.55	4.14
substantia nigra, newborn, donor10223	10358-105E7	50.17	3.53	0.00	0.71	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	93.54	12.38	3.21	0.69	1.38	0.46
temporal lobe, adult, pool1	10031-101E4	27.38	3.98	1.36	3.22	2.20	2.80
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.89	12.82	0.71	6.41	3.56	7.12
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.48	6.15	1.76	3.52	3.52	4.83
tenocyte, donor1	11763-123H8	52.02	2.44	0.70	0.70	1.40	3.14
tenocyte, donor2	11765-123I1	62.57	6.49	1.91	3.05	1.53	0.76
tenocyte, donor3	11768-123I4	46.70	4.08	1.11	0.37	0.74	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	58.47	4.42	1.02	0.00	0.51	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	62.12	3.70	2.16	2.00	0.46	0.77
teratocarcinoma cell line:PA-1	10807-111A6	88.96	4.49	0.46	1.24	0.62	2.01
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	46.72	5.71	1.40	0.63	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	38.95	3.03	0.76	0.38	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	50.82	3.38	1.09	0.22	0.00	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	70.03	3.91	0.33	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	146.78	9.34	11.49	1.18	0.43	1.50
testis, adult, pool2	10096-102C6	156.98	7.22	18.04	1.35	0.90	1.80
thalamus - adult, donor10196	10168-103B6	38.64	4.42	0.00	2.21	6.62	4.42
thalamus, adult, donor10252	10154-103A1	37.35	3.91	0.94	4.84	2.66	3.59
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	4.62	0.00	1.54	4.62	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.67	3.95	0.82	3.62	2.47	4.94
thalamus, newborn, donor10223	10366-105F6	29.34	1.73	1.15	4.60	2.30	0.58
throat, adult	10209-103G2	32.46	4.99	1.75	1.25	0.75	0.50
throat, fetal, donor1	10061-101H7	47.23	6.09	0.00	0.00	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	82.67	11.33	1.39	0.20	0.00	0.40
thymus, adult, pool1	10027-101D9	70.68	8.95	1.89	0.60	0.10	0.10
thymus, fetal, pool1	10043-101F7	84.79	7.59	2.18	0.94	0.62	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	66.88	10.77	1.60	0.53	0.27	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	73.20	9.08	0.70	1.54	0.56	0.56
thyroid, adult, pool1	10028-101E1	61.87	7.56	1.31	1.03	0.75	0.19
thyroid, fetal, donor1	10060-101H6	44.82	7.65	1.05	0.53	0.26	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	42.79	7.21	0.47	0.23	0.23	0.47
tongue, fetal, donor1	10059-101H5	44.53	8.67	0.79	0.39	0.00	0.79
tonsil, adult, pool1	10047-101G2	69.42	7.61	1.00	0.30	0.70	0.30
trachea, adult, pool1	10029-101E2	46.87	4.50	0.90	0.16	0.33	0.25
trachea, fetal, donor1	10058-101H4	48.86	6.54	0.77	0.00	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	41.45	3.90	1.06	0.00	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	54.81	6.59	1.62	0.00	0.00	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	198.05	15.67	3.76	5.95	2.04	3.92
tridermal teratoma cell line:HGRT	10694-109G1	19.03	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.53	1.44	0.51	0.42	0.34	0.51
umbilical cord, fetal, donor1	10057-101H3	22.95	4.17	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	65.35	2.05	1.54	0.17	0.34	0.34
uterus, fetal, donor1	10055-101H1	52.73	14.85	1.02	1.54	1.02	1.02
vagina, adult	10204-103F6	23.91	2.58	0.00	1.94	1.29	0.00
vein, adult	10191-103E2	49.54	2.63	0.88	0.44	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	70.76	2.14	1.07	0.27	0.00	0.80